Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Einstein researchers develop blood substitute that shows promise for use in emergency situations

02.12.2003


An artificial blood product developed by researchers at the Albert Einstein College of Medicine of Yeshiva University is showing great promise in ongoing clinical trials in Stockholm, Sweden - the first time that a blood substitute has ever been used successfully in humans. The Einstein researchers - whose work is supported by $2.2 million in grants from the National Institutes of Health and the U.S. Army -- are also fine-tuning a powder version of the substitute that can be reconstituted for use as needed with the simple addition of water.



An October 23rd BBC News article describing the Stockholm trials quoted one enthusiastic researcher, Dr. Pierre LaFolie, chief physician at Karolinska Hospital in Sweden, "If this really works all the way, then mankind will have taken a big step forward."

The leader in developing the blood product is Dr. Seetharama Acharya, professor of medicine and of biophysics and physiology at Einstein. Using blood from donated supplies - whose shelf life for use in transfusions is generally limited to 42 days - Dr. Acharya developed the technology that makes the hemoglobin removed from "old" red blood cells suitable for use in transfusions.


"With our blood product, the issue of blood typing is removed," says Dr. Acharya.
"Patients with any blood type can receive the artificial blood, which then transports oxygen
through the body to help limit damage at a time when loss of blood can lead to death."

"When time is of the essence - on the battlefield, for example - being able to provide a blood transfusion without the need for typing can save critical seconds," said Dr. Joel Friedman, professor of biophysics and physiology at Einstein and principal investigator of the NIH-funded project. "The same could be said of an accident scene with multiple injuries or emergency surgeries. Our product offers a viable bridge during emergency situations for providing a blood product that complements the individual’s own blood while transporting oxygen vital to the person’s well-being."

Initial clinical trials are taking place at Sweden’s Karolinska Hospital. The product being studied was produced by a pharmaceutical company that has licensed the technology for making the blood substitute from its Einstein inventors. Thus far, eight patients have been tested, with none demonstrating signs either of rejection or of any of the potential deleterious side effects, such as hypertension, that have been observed with many of the earlier candidates for use as blood substitutes.

The study also showed that this artificial blood transported even more oxygen throughout the body than real blood, which can help to limit tissue damage associated with oxygen deprivation.

"The implications for the use of a blood substitute like ours could be far-reaching," said Dr. Friedman. "We’re very excited about the many potential uses for this product and, using the support from the NIH and U.S. Army, plan to fine-tune and perfect it through further testing that will ultimately lead to its use in real-life emergency situations."

Karen Gardner | AECM
Further information:
http://www.aecom.yu.edu/home/news/subblood.htm

More articles from Health and Medicine:

nachricht The genes are not to blame
20.07.2018 | Technische Universität München

nachricht Targeting headaches and tumors with nano-submarines
20.07.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Future electronic components to be printed like newspapers

A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.

The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

A smart safe rechargeable zinc ion battery based on sol-gel transition electrolytes

20.07.2018 | Power and Electrical Engineering

Reversing cause and effect is no trouble for quantum computers

20.07.2018 | Information Technology

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern

20.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>